4-Pyridylboronic Acid CAS 1692-15-5 Kuchena ≥99.5% (HPLC) Factory Hot Sale
Manufacturer Supply, High Purity, Commercial Production
Zita reKemikari: 4-Pyridylboronic AcidCAS: 1692-15-5
Chemical Name | 4-Pyridylboronic Acid |
Mashoko anoreva zvakafanana | Pyridine-4-Boronic Acid |
Nhamba yeCAS | 1692-15-5 |
Nhamba yeCAT | RF-PI571 |
Stock Status | MuStock, Kukwanisa Kugadzira 25 Matani / Mwedzi |
Molecular Formula | C5H6BNO2 |
Molecular Weight | 122.92 |
Solubility | Insoluble muMvura |
Melting Point | >300 ℃ (lit.) |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | White Powder |
Kuchena / Analysis Method | >99.5% (HPLC) |
Kunyorova (naKarl Fischer) | <0.50% |
Kusachena Kumwechete | <0.50% |
Zvose Zvisina Kuchena | <0.50% |
Heavy Metals (as Pb) | <20ppm |
Test Standard | Enterprise Standard |
Usage | Pharmaceutical Intermediates |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://www.ruifuchemical.com/uploads/23.jpg)
4-Pyridylboronic Acid (CAS: 1692-15-5) inogona kushandiswa semumiriri weSuzuki-Miyaura coupling reaction.Kunyanya, seN-ine zvivharo zvekuvaka, pyridine-4-boronic acid yakashandiswa kugadzira mamwe majekiseni eheterocyclic ane zviitiko zvepamusoro zvehupenyu.4-Pyridylboronic Acid imhando ye boronic acid inotorwa.Inobatsira zvivakwa zvekuvaka mucrystal engineering.Inogona zvakare kushandiswa sechinhu chinokonzeresa kuita senge dehydrative condensation mumiriri kugadzira amides uchishandisa carboxylic acid uye amines seyakagadzirwa zvinhu.Kubva kwayo, polystyrene-yakasungwa 4-pyridineboronic acid, inobatsira inokonzeresa amidation reaction uye esterification yealpha-hydrocarboxylic acids.
Reagent inoshandiswa: Palladium-catalyzed Suzuki-Miyaura coupling reactions;Ligand-isina palladium-catalyzed Suzuki coupling reaction pasi pe microwave irradation;Reagent inoshandiswa mu: Kugadzirira kweHIV-1 protease inhibitors;Zvinogona kuitika kenza threapeutics, senge PDK1 uye protein kinase CK2 inhibitors.